XBP Global (XBP) Q2 2026 earnings review
Surging Bookings and Margins Mask Ongoing Revenue Decay
XBP Global is executing a massive structural shift, and the financials are showing a deep divergence. On the negative side, pro forma revenue contracted by a severe 14.0% YoY, extending a multi-quarter streak of double-digit top-line decay. On the positive side, an aggressive AI-led automation strategy is succeeding: Adjusted Gross Margin hit a record 24.9%, and Normalized EBITDA grew 8.4% to $21.9M. More importantly, forward-looking bookings are flashing a turnaround signal, with Total Contract Value (TCV) surging 51.6% YoY. The company is extracting significantly more profit from a shrinking base while building a pipeline to eventually arrest the revenue decline.
🐂 Bull Case
TCV bookings hit $121.3M (+51.6% YoY) and new Annual Contract Value (ACV) jumped 57.0%. At over 40% above the trailing four-quarter average, this pipeline surge is the leading indicator needed for a future return to growth.
The transition to agentic AI-driven automation is yielding structural benefits. Adjusted Gross Margin reached an all-time high of 24.9% (up 290 bps YoY), allowing the company to raise its annualized efficiency target to $65-$75M.
🐻 Bear Case
Despite the bookings optimism, current period revenue is still plunging, down 14.0% YoY to $191.3M. The legacy business runoff is currently outpacing the onboarding of new contracts.
Total cash and restricted cash collapsed from $68.7M in December 2025 to just $28.0M by June 2026. Restructuring costs and legacy debt obligations are burning cash faster than core operations can replenish it.
⚖️ Verdict: ⚪
Neutral. The operational turnaround is gaining serious traction with record margins and surging pipeline numbers. However, massive cash burn and persistent double-digit revenue declines present near-term execution risks that cap the upside until the top line officially bottoms.
Key Themes
Bookings Pipeline Turnaround
Accelerating. Forward-looking metrics are heavily contradicting the current revenue decay. Q2 TCV closed at $121.3M (up 51.6% YoY), and new ACV closed at $36.0M (up 57.0% YoY). Both metrics are running roughly 40% above their trailing four-quarter averages. Demand is particularly robust in healthcare for secure, on-premise automation with strict data sovereignty.
AI-First Automation Efficiencies
Accelerating. The rollout of proprietary, agentic AI-driven workflow platforms is structurally changing the cost base. This direct technological implementation led management to increase its annualized operational efficiency target to $65-$75M, expecting to realize ~$35M within 2026 alone. This is the primary catalyst behind the 290 bps expansion in Adjusted Gross Margin.
Favorable Revenue Mix Shift
Stable. The company explicitly noted that the record profitability was driven not just by cost-cutting, but by a 'favorable revenue mix.' As XBP transitions clients from lower-margin, labor-intensive processes (legacy Applied Workflow Automation) to higher-margin technology platforms and AI orchestration, margin profiles mathematically improve even as overall volumes drop.
Severe Liquidity Drain Contradicts Margin Narrative
Reversing. While management touts a record $21.9M in Normalized EBITDA, the balance sheet tells a much darker story. Total cash and restricted cash plummeted 59% from $68.7M at year-end 2025 to just $28.0M by the end of Q2 2026. Operating activities consumed $15.2M in cash during H1. High interest expenses ($28.0M in H1) and restructuring costs mean the 'profitability' is not currently flowing to the bank.
Persistent Legacy Revenue Contraction
Stable. The top line is bleeding out at a consistent mid-teens rate: down 18.1% in 25Q3, 13.6% in 25Q4, 14.2% in 26Q1, and now 14.0% in 26Q2. While the bookings surge is excellent, it has not yet proven it can outpace the runoff of legacy contracts and churn. The transition phase remains a high-risk gap to bridge.
Public Sector Macro Volatility
Management directly flagged that 'timing on public sector contracts remains volatile.' Given the current macroeconomic and political backdrop, relying heavily on government agencies to execute complex, high-value digital transformations introduces significant quarter-to-quarter revenue recognition risk.
Strategic Alternatives in Play
The company has formally engaged a financial advisor to explore strategic alternatives. Having heavily restructured the debt stack in 2025 and proven out the AI margin expansion model in H1 2026, the Board appears to be looking for a liquidity event, sale, or structural pivot to maximize stakeholder value before the cash runway tightens further.
Other KPIs
Accelerating. Up 8.4% YoY on a pro forma basis, a remarkable achievement given the 14% drop in top-line revenue. This clearly validates the aggressive restructuring and AI automation thesis. The gap between falling revenues and rising EBITDA highlights maximum operational leverage.
Accelerating. A record high for the company, expanding 290 basis points year-over-year. Even on a GAAP basis, gross margin expanded 80 bps to 21.5%.
Guidance
Accelerating. Raised significantly from the previous target of $55 - $60 million. Management expects to realize approximately $35 million of this benefit strictly within calendar year 2026, providing a massive tailwind to H2 profitability metrics.
Key Questions
Revenue Bottom
With TCV and ACV surging over 50% year-over-year, exactly when do you expect these bookings to arrest the 14% top-line decay and return XBP to positive sequential revenue growth?
Cash Runway vs Reorganization
Total cash reserves dropped by $40M in six months. With $28M left on the balance sheet and operating cash flow still negative, will you need to tap external capital before the AI cost savings fully hit the bottom line?
Public Sector Exposure
You noted volatility in public sector contract timing. What percentage of the $121M TCV booked this quarter is tied to the public sector, and how much is at risk of sliding into 2027?